全球生物功能晶片市場(OOC):預測(2023-2028)
市場調查報告書
商品編碼
1410141

全球生物功能晶片市場(OOC):預測(2023-2028)

Organs-on-Chip Market - Forecasts from 2023 to 2028

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計2021年全球生物功能晶片(OOC)市場規模將達到74,827,000美元,預測期內複合年成長率為26.72%,2028年將達到392,621,000美元。

有機功能晶片(OOC)是一種含有活細胞的功能微晶片,具有模擬整個器官或器官系統的活動、動態和生理反應的潛力,是人造器官的一種。每個生物功能晶片大約有硬幣大小,包含微流體通道,排列有活的人體細胞,並與人體人工脈管系統連接。生物功能晶片(OOC)市場的推動因素包括對有效藥物研發發現和研發的需求不斷成長、研究中對動物模型替代品的需求不斷成長、藥物重複利用方法的增加以及政府研究法規和津貼。因此,我們持續成長穩定。此外,生物功能晶片(OOC)模型開發的研究和資金的增加、個人化醫療的需求以及疾病建模、患者分層和表現型篩檢等晶片的廣泛應用也是推動市場成長的因素。

然而,晶片的高成本和模仿人體器官的複雜性為市場的持續成長帶來了挑戰。因此,領先的公司和研究人員正在簽訂協議和成立合資企業,以增加創新新產品研究和開發的資金。

該研究報告根據類型、應用、產品、最終用戶和區域等各個細分市場對市場進行了研究。首先簡要介紹了市場概況,詳細介紹了主要促進因素和挑戰。接下來我們利用波特五力模型對生物功能晶片產業進行全面分析。隨後,價值鏈分析確定了屬於不同流程、對不同領域做出貢獻的公司。

它還提供了有關影響生物功能晶片市場的市場開拓、趨勢、行業政策和法規的詳細資訊。此外,本研究分析了生物功能晶片產業的整體法規結構,旨在讓相關人員更了解影響整體市場環境的關鍵因素。

《全球生物功能晶片市場 (OOC):預測(2023-2028 年)》是一份綜合性的新報告。向管理層和有興趣的相關人員提供關鍵的市場訊息,並提供重要的市場資訊。它還分析了主要市場參與者的競爭形勢和詳細策略,並將其繪製在四象限供應商矩陣中:領導者、追隨者、挑戰者和利基市場。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 先決條件

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場抑制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章生物功能晶片(OOC)市場:按類型

  • 介紹
  • 其他

第6章生物功能晶片(OOC)市場:依應用

  • 介紹
  • 藥物研發
  • 毒性試驗
  • 生理模型

第7章生物功能晶片(OOC)市場:透過提供

  • 介紹
  • 產品
  • 服務

第8章生物功能晶片(OOC)市場:依最終用戶分類

  • 介紹
  • 研究機構
  • 製藥公司

第9章生物功能晶片(OOC)市場:按地區

  • 介紹
  • 美洲
    • 美國
    • 其他
  • 歐洲/中東/非洲
    • 德國
    • 英國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 其他

第10章競爭環境及分析

  • 主要企業及策略分析
  • 新興企業和市場盈利
  • 併購/協議/合作
  • 供應商競爭力矩陣

第11章 公司簡介

  • AxoSim Inc.
  • BiomimX SRL
  • CN Bio
  • Emulate Inc.
  • InSphero AG
  • MIMETAS BV
  • Nortis Inc.
  • TissUse GmbH.
簡介目錄
Product Code: KSI061612935

The organs-on-chip market was valued at US$74.827 million in 2021 and is projected to expand at a CAGR of 26.72% over the forecast period to reach US$392.621 million by 2028.

An organ-on-a-chip (OOC) is a functional microchip housing living cells that have the possibility of simulating the activities, mechanics, and physiological response of entire organs and organ systems, a type of artificial organ. Each organ-on-chip is about the size of a coin and contains microfluidic channels, which are lined by living human cells and interfaced with a human artificial vasculature. The organs-on-chip market has been on a steady growth pace because of the rising need for effective drug discovery and development, increasing demand for alternatives for animal models in research, increasing drug repurposing approaches, and government regulations and grants for the research. The increasing research and funding for the development of the organ-on-chip model, along with the demand for personalized medication and vast application of the chip, such as disease modelling, patient stratification, and phenotypic screening, has also led to market growth.

However, the high cost of the chip and the complexities of mimicking human organs pose a challenge for the growth of the market to continue. Therefore, the key players and researchers are doing agreements and joint ventures and increasing the fund for doing research and developing innovative and new products.

This research study examines the organs-on-chip market based on various segments: type, application, offerings, end-user, and geography. First, a brief overview of the market details key driving factors and challenges. Next, Porter's five forces model comprehensively analyzes the organs-on-chip industry. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.

The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the organs-on-chip market. Moreover, the research study analyzes the overall regulatory framework of the organs-on-chip sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.

Organs-on-chip Market - Forecasts from 2023 to 2028 is a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape and details strategies of key market players and also plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.

The scope and coverage of the organs-on-chip market report is as below:

  • Organs-on-chip market data tables and charts
  • Market outlook with sections on drivers, restraints, Porter's, and industry value chain analysis
  • Market assessment by type into liver, kidney, lung, heart, and others.
  • Detailed market trends, analysis, and graphical representation by application into drug discovery, toxicity testing, and physiological model and by offering into products and services.
  • In-depth analysis of the organs-on-chip market by end-user into research institutes and pharmaceutical companies.
  • A 360o view of the demand for organs-on-chip solutions/services across different geographies (Americas, Europe, Middle East and Africa, and Asia Pacific) with further breakdown for key countries within those regions.

Different segments covered under the organs-on-chip market report are as below:

By Type

  • Liver
  • Kidney
  • Lung
  • Heart
  • Others

By Application

  • Drug Discovery
  • Toxicity Testing
  • Physiological Model

By Offering

  • Products
  • Services

By End-User

  • Research Institute
  • Pharmaceutical Companies

By Geography

  • Americas
  • USA
  • Others
  • Europe, Middle East, and Africa
  • Germany
  • United Kingdom
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. ORGANS ON CHIP MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Liver
  • 5.3. Kidney
  • 5.4. Lung
  • 5.5. Heart
  • 5.6. Others

6. ORGANS ON CHIP MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Drug Discovery
  • 6.3. Toxicity Testing
  • 6.4. Physiological Model

7. ORGANS ON CHIP MARKET, BY OFFERING

  • 7.1. Introduction
  • 7.2. Products
  • 7.3. Services

8. ORGANS ON CHIP MARKET, BY END-USER

  • 8.1. Introduction
  • 8.3. Research Institutes
  • 8.4. Pharmaceutical Companies

9. ORGANS ON CHIP MARKET, BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. Americas
    • 9.2.1. USA
    • 9.2.2. Others
  • 9.3. Europe, Middle East and Africa
    • 9.3.1. Germany
    • 9.3.2. United Kingdom
    • 9.3.3. Others
  • 9.4. Asia Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. South Korea
    • 9.4.4. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

  • 11.1. AxoSim Inc.
  • 11.2. BiomimX SRL
  • 11.3. CN Bio
  • 11.4. Emulate Inc.
  • 11.5. InSphero AG
  • 11.6. MIMETAS BV
  • 11.7. Nortis Inc.
  • 11.8. TissUse GmbH.